Instrumentarium Imaging and Nycomed Amersham are the latest medical device companies to promote themselves through e-business. Instrumentarium announced this month that it intends to join the Global Healthcare Exchange, a consortium of medical
Instrumentarium Imaging and Nycomed Amersham are the latest medical device companies to promote themselves through e-business. Instrumentarium announced this month that it intends to join the Global Healthcare Exchange, a consortium of medical device companies, while Nycomeds announcement came just last week.
Abbott Laboratories, Baxter International, GE Medical Systems, Johnson & Johnson, and Medtronic founded the exchange this past spring (SCAN 4/14/00). The site will provide access to product catalogues and online ordering and status confirmation. The exchange is expected to launch this fall in the U.S. and to expand worldwide.
The five companies, plus Instrumentarium, Nycomed, and other companies that have since joined, are equal partners in ownership of the healthcare exchange. The exchange is set to launch at the end of September, when it will announce its final name.
Nycomed specializes in imaging agents and oncology therapies. Instrumentarium of Finland specializes in anesthesia and other medical equipment.
The online exchange will offer medical devices, imaging products, and accessories from a variety of manufacturers. Exchange creators say customers will probably be hospitals and acute-care clinics. They will be able to simultaneously order equipment and get clinical information about products.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.